TC
TTOO

TFS Capital’s T2 Biosystems, Inc TTOO Stock Holding History

TFS Capital’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4
Closed -$154K – 1033
2016
Q2 		$154K Sell
4
-2
-33% -$90.3K 0.03% 790
2016
Q1 		$315K Buy
6
+1
+20% +$44.2K 0.05% 632
2015
Q4 		$270K Sell
5
-7
-58% -$378K 0.03% 539
2015
Q3 		$531K Buy
+12
New +$797K 0.05% 507

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TFS Capital's TTOO Position: Q3 2016 in Review

TFS Capital sold out of T2 Biosystems, Inc (TTOO) in Q3 2016, closing a stake of 4 shares — an estimated $154K sold.

TFS Capital first reported a position in TTOO in Q3 2015 and held it in 4 quarters. The position peaked at $531K in Q3 2015. 41 funds tracked by Wall St. Rank hold TTOO as of Q3 2016.

  • TFS Capital reported no remaining T2 Biosystems, Inc position as of Q3 2016 after selling out during the quarter.
  • TFS Capital sold 4 T2 Biosystems, Inc shares in Q3 2016, an estimated $154K.
  • TFS Capital first reported a position in T2 Biosystems, Inc in Q3 2015 and held it in 4 quarters.
  • TFS Capital's T2 Biosystems, Inc position peaked at $531K in Q3 2015.
  • 41 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2016.

Based on TFS Capital's 13F filing for Q3 2016, filed 10 Nov 2016.